オリヅルセラピューティクス株式会社
Fujisawa, JP · 4 known investors
Orizuru Therapeutics develops cellular therapy products and regenerative medicine treatments utilizing iPS cell-related technology. The company supports drug discovery research and establishes regenerative medicine research infrastructure for the Japanese healthcare and biotechnology sectors.
Founders & leadership
KN
Kenji Nonaka代表取締役 (CEO)
Investors · 4
Frequently asked questions
- What does オリヅルセラピューティクス株式会社 do?
- Orizuru Therapeutics develops cellular therapy products and regenerative medicine treatments utilizing iPS cell-related technology. The company supports drug discovery research and establishes regenerative medicine research infrastructure for the Japanese healthcare and biotechnology sectors.
- Who are オリヅルセラピューティクス株式会社's investors?
- オリヅルセラピューティクス株式会社's investors include Kyoto University Innovation Capital, SMBC Venture Capital, Sumitomo Mitsui Trust Bank, JDRF T1D Fund.
- Where is オリヅルセラピューティクス株式会社 headquartered?
- オリヅルセラピューティクス株式会社 is headquartered in Fujisawa, JP.